• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Unilife Corp.

Unilife raises $60M through debt financing, shares soar

March 13, 2014 By drugdelivery

Unilife raises $60M through debt financing

Pennsylvania device maker Unilife (NSDQ:UNIS) raised $60 million through a debt financing agreement with OrbiMed Advisors, news of which sent UNIS shares soaring today.

Filed Under: Drug-Device Combinations Tagged With: OrbiMed, Unilife Corp.

Shareholders lawsuit against Unilife fizzles

January 23, 2014 By Brad Perriello

Shareholders lawsuit against Unilife fizzles

The plaintiff in a purported class action shareholders lawsuit against Unilife (NSDQ:UNIS) voluntarily withdrew the complaint after no other stockholders stepped up to join the suit.

Filed Under: Drug-Device Combinations Tagged With: Unilife Corp.

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS